Help me understand Mr Chairman

Mr Chairman, as you know,I’ll be Voting No,but help me understand why you want to sell the company now and forthis price:

• Your executives are excited about the company and unanimously believe that the company is at the beginning of a strong growth and profitability period. (See my previous post)

• NYU Stern Business School research shows that Drug (Pharmaceutical) companies trade at price/sales multiples of 4.84 based on 231 companies. You are giving the company away for multiples of just over 1.

• I get it, the Australian share market has not realised that the company has changed in the last 2 years and has not valued the company appropriately, but Cosette knows its true value, and it’s not $7.4

• Why are Australian investors being short-changed, with significant value potentially shifting to U.S. private investors.?

• Why recommend selling a company just as it is thriving, rather than allowing shareholders to reap the benefits of its ongoing growth?

• Why are Mayne Pharma’s shareholders forced to sell their stake in what could be a much more valuable company in the years ahead?

• Who truly benefits from this deal?

Theseare just questions which you may consider explaining to shareholdersin your forthcoming Scheme Booklet.